JP2003509470A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2003509470A5 JP2003509470A5 JP2001524625A JP2001524625A JP2003509470A5 JP 2003509470 A5 JP2003509470 A5 JP 2003509470A5 JP 2001524625 A JP2001524625 A JP 2001524625A JP 2001524625 A JP2001524625 A JP 2001524625A JP 2003509470 A5 JP2003509470 A5 JP 2003509470A5
- Authority
- JP
- Japan
- Prior art keywords
- antigen
- epitope
- administration
- combination
- composition
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
- 239000000427 antigen Substances 0.000 description 15
- 102000036639 antigens Human genes 0.000 description 15
- 108091007433 antigens Proteins 0.000 description 15
- 230000037452 priming Effects 0.000 description 8
- 239000003814 drug Substances 0.000 description 6
- 210000001744 T-lymphocyte Anatomy 0.000 description 5
- 230000028993 immune response Effects 0.000 description 3
- 241000700605 Viruses Species 0.000 description 2
- 238000007918 intramuscular administration Methods 0.000 description 2
- 150000007523 nucleic acids Chemical class 0.000 description 2
- 102000039446 nucleic acids Human genes 0.000 description 2
- 108020004707 nucleic acids Proteins 0.000 description 2
- 241000701161 unidentified adenovirus Species 0.000 description 2
- 230000002950 deficient Effects 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 230000000069 prophylactic effect Effects 0.000 description 1
- 230000010076 replication Effects 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB9922361.2 | 1999-09-21 | ||
| GBGB9922361.2A GB9922361D0 (en) | 1999-09-21 | 1999-09-21 | Generating an immune response to an antigen |
| PCT/GB2000/003601 WO2001021201A2 (en) | 1999-09-21 | 2000-09-20 | Use of replication-deficient adenoviral vector to boost cd8+ t cell immune response to antigen |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2003509470A JP2003509470A (ja) | 2003-03-11 |
| JP2003509470A5 true JP2003509470A5 (enExample) | 2007-10-18 |
Family
ID=10861351
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2001524625A Withdrawn JP2003509470A (ja) | 1999-09-21 | 2000-09-20 | 抗原に対するｃｄ８＋ｔ細胞免疫応答を増強するための複製欠損性アデノウイルスベクターの使用 |
Country Status (12)
| Country | Link |
|---|---|
| EP (2) | EP1612269A1 (enExample) |
| JP (1) | JP2003509470A (enExample) |
| CN (1) | CN1391609A (enExample) |
| AT (1) | ATE295421T1 (enExample) |
| AU (1) | AU762894B2 (enExample) |
| BR (1) | BR0014138A (enExample) |
| CA (1) | CA2384806A1 (enExample) |
| DE (1) | DE60020136T2 (enExample) |
| DK (1) | DK1214416T3 (enExample) |
| ES (1) | ES2241653T3 (enExample) |
| GB (1) | GB9922361D0 (enExample) |
| WO (1) | WO2001021201A2 (enExample) |
Families Citing this family (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB9711957D0 (en) | 1997-06-09 | 1997-08-06 | Isis Innovation | Methods and reagents for vaccination |
| EP1200622A4 (en) | 1999-07-06 | 2004-12-22 | Merck & Co Inc | HIV VACCINE FROM AN ADENOVIRUS CARRYING THE GAG GENE |
| US6733993B2 (en) | 2000-09-15 | 2004-05-11 | Merck & Co., Inc. | Enhanced first generation adenovirus vaccines expressing codon optimized HIV1-gag, pol, nef and modifications |
| GB0118532D0 (en) * | 2001-07-30 | 2001-09-19 | Isis Innovation | Materials and methods relating to improved vaccination strategies |
| WO2003097087A1 (en) * | 2002-05-20 | 2003-11-27 | Japan Science And Technology Agency | Bcg vaccine and utilization thereof |
| US20080153083A1 (en) | 2003-10-23 | 2008-06-26 | Crucell Holland B.V. | Settings for recombinant adenoviral-based vaccines |
| EP1553983A2 (en) | 2002-10-23 | 2005-07-20 | Crucell Holland B.V. | New settings for recombinant adenoviral-based vaccines |
| CN100410382C (zh) * | 2006-08-18 | 2008-08-13 | 上海交通大学医学院 | 一种可诱生细胞免疫应答的共表达载体和真核表达载体 |
| AU2007322075B2 (en) * | 2006-11-17 | 2013-07-25 | Genetronics, Inc. | Methods of enhancing immune response using electroporation-assisted vaccination and boosting |
| GB0706912D0 (en) * | 2007-04-10 | 2007-05-16 | Isis Innovation | Novel viral vaccines |
| GB0706914D0 (en) | 2007-04-10 | 2007-05-16 | Isis Innovation | Novel adenovirus vectors |
| JP5710254B2 (ja) * | 2007-09-14 | 2015-04-30 | アンスティテュ・パストゥールＩｎｓｔｉｔｕｔ Ｐａｓｔｅｕｒ | 外来エピトープを含む組換え偽ウイルスの発現および分泌を可能とするポリヌクレオチド、それらの製造および使用 |
| GB0823497D0 (en) * | 2008-12-24 | 2009-01-28 | Isis Innovation | Immunogenic composition and use thereof |
| PT2912183T (pt) * | 2012-10-28 | 2020-06-05 | Bavarian Nordic As | Promotor pr13.5 para respostas robustas de células t e anticorpos |
| KR20230166145A (ko) | 2017-03-15 | 2023-12-06 | 옥스포드 바이오메디카(유케이) 리미티드 | 방법 |
| MX2022004484A (es) * | 2019-10-16 | 2022-07-19 | Cancer Research Tech Ltd | Vector para el tratamiento de cancer. |
| US20230310591A1 (en) | 2021-12-07 | 2023-10-05 | Vaccitech (Uk) Limited | Vaccine Boost Methods and Compositions |
| WO2024218165A1 (en) | 2023-04-17 | 2024-10-24 | Barinthus Biotherapeutics (Uk) Limited | Hpv viral vector vaccine |
-
1999
- 1999-09-21 GB GBGB9922361.2A patent/GB9922361D0/en not_active Ceased
-
2000
- 2000-09-20 CN CN00815933A patent/CN1391609A/zh active Pending
- 2000-09-20 WO PCT/GB2000/003601 patent/WO2001021201A2/en not_active Ceased
- 2000-09-20 CA CA002384806A patent/CA2384806A1/en not_active Abandoned
- 2000-09-20 AT AT00960857T patent/ATE295421T1/de not_active IP Right Cessation
- 2000-09-20 EP EP05009308A patent/EP1612269A1/en not_active Withdrawn
- 2000-09-20 DK DK00960857T patent/DK1214416T3/da active
- 2000-09-20 ES ES00960857T patent/ES2241653T3/es not_active Expired - Lifetime
- 2000-09-20 EP EP00960857A patent/EP1214416B1/en not_active Revoked
- 2000-09-20 DE DE60020136T patent/DE60020136T2/de not_active Revoked
- 2000-09-20 AU AU73024/00A patent/AU762894B2/en not_active Ceased
- 2000-09-20 JP JP2001524625A patent/JP2003509470A/ja not_active Withdrawn
- 2000-09-20 BR BR0014138-0A patent/BR0014138A/pt not_active Application Discontinuation
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2003509470A5 (enExample) | ||
| Ertl et al. | Novel vaccine approaches. | |
| JP2001081042A5 (enExample) | ||
| Ulmer et al. | DNA vaccines | |
| EP0979284B2 (en) | Reagents for vaccination which generate a cd8 t cell immune response | |
| JP2003535043A5 (enExample) | ||
| JP2004511201A5 (enExample) | ||
| JP2002542827A5 (enExample) | ||
| JP2005508916A5 (enExample) | ||
| GB2384709A (en) | Vaccination method | |
| JP2000516200A (ja) | ウシの呼吸病に対するポリヌクレオチドワクチン処方 | |
| JP2006501825A5 (enExample) | ||
| JP2003530307A5 (enExample) | ||
| Plotkin | Six revolutions in vaccinology | |
| WO2003047617A3 (en) | Vaccine | |
| JP2016513115A5 (enExample) | ||
| CA2419822A1 (en) | Modifications of hiv env, gag, and pol enhance immunogenicity for genetic immunization | |
| JP2003519197A5 (enExample) | ||
| JP2024105526A5 (enExample) | ||
| GB9922361D0 (en) | Generating an immune response to an antigen | |
| JP2004501650A5 (enExample) | ||
| WO2006037038B1 (en) | Optimized vaccines to provide protection against ebola and other viruses | |
| Saeedi et al. | Enhanced cell immune responses to hepatitis C virus core by novel heterologous DNA prime/lambda nanoparticles boost in mice | |
| JP2010523138A5 (enExample) | ||
| WO2000063406A3 (en) | Adenoviral vectors having nucleic acids encoding immunomodulatory molecules |